These results are underlined by several other recent papers: In ovarian carcinomas, it was shown that phospho-ERK1/2 as well as a low expression of BIM are biomarkers for absence of response to ABT-737 [58]. The gene discussed is MAPK3; the disease is ovarian carcinoma.